Total planned funding: $267,561,007
Allocations
Countries/Regions
| Eswatini | $267,561,007 |
Organizational Types
| Private Contractor | $68,641,703 |
| NGO | $56,019,652 |
| University | $48,009,828 |
| Unknown | $43,663,681 |
| Own Agency | $29,590,652 |
| Multi-lateral Agency | $12,164,416 |
| Host Country Government Agency | $5,286,115 |
| Other USG Agency | $2,400,287 |
| FBO | $1,538,242 |
| Implementing Agency | $246,431 |
Program Areas
| Care | $77,621,358 |
| Treatment | $75,234,939 |
| Prevention | $51,080,081 |
| Governance and Systems | $31,992,760 |
| Management and Operations | $16,013,215 |
| Testing | $15,618,654 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $53,594,362 |
| HBHC: Care: Adult Care and Support | $31,812,446 |
| HKID: Care: Orphans and Vulnerable Children | $24,296,871 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $20,360,790 |
| HVSI: Strategic Information | $19,209,320 |
| HVMS: Management and Operations | $16,013,215 |
| HTXD: Treatment: ARV Drugs | $15,999,099 |
| HVCT: Testing: HIV Testing and Counseling | $15,618,654 |
| HVTB: Care: TB/HIV | $14,395,065 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $13,389,692 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $12,050,878 |
| OHSS: Health Systems Strengthening | $8,837,564 |
| PDCS: Care: Pediatric Care and Support | $7,116,976 |
| PDTX: Treatment: Pediatric Treatment | $5,641,478 |
| HLAB: Laboratory Infrastructure | $3,945,876 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,626,935 |
| HMBL: Biomedical Prevention: Blood Safety | $1,651,786 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$43,663,681
Countries/Regions
Columbia University:
$40,272,236
Countries/Regions
Pact, Inc.:
$27,521,015
Countries/Regions
USG Aggregated Agencies:
$24,960,056
Countries/Regions